PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Global Health,International Clinical Research Center (ICRC), University of Washington, UW Box 359927, 325 Ninth Avenue, Seattle, WA, 98104, USA. rbarnaba@uw.edu.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Department of Epidemiolog, University of Washington, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Biostatistics, University of Washington, Seattle, WA, USA.\', \'New York University School of Medicine, New York, NY, USA.\', \'Bill and Melinda Gates Foundation, Seattle, WA, USA.\', \'Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.\', \'Department of Global Health,International Clinical Research Center (ICRC), University of Washington, UW Box 359927, 325 Ninth Avenue, Seattle, WA, 98104, USA.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.\', \'Department of Epidemiolog, University of Washington, Seattle, WA, USA.\', \'Certara, Princeton, NJ, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04446-4
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32493478
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all